Insights

Animal Health Leadership Elanco’s strong focus on animal care and sustainability presents opportunities to position companion and livestock health solutions that align with their mission, with emphasis on expanding value through preventive care, diagnostics, and long-term animal well-being programs.

Sustainability-Driven Growth Their commitment to creating a more sustainable world suggests potential for partnerships around sustainable farming practices, reduced-needles innovation, and cost-efficient formulations that appeal to customers seeking eco-friendly and welfare-focused products.

Digital Enablement Adoption of TOGAF, Veeva Vault, IBM Maximo, Azure AI Services, and Tableau indicates openness to integrated digital solutions; sales opportunities exist for cloud-based data platforms, analytics, and IT services to streamline regulatory, supply, and customer-facing processes.

Scale and Reach With a sizable global employee base and a revenue range in the billions, Elanco represents a broad market for product extensions, regional partnerships, and channel optimization across veterinary products, farm animal health, and innovative delivery systems.

Strategic Partnerships Competitive landscape includes large players like Zoetis and Merck; opportunities may lie in co-development, exclusive distribution, or value-added services that differentiate Elanco’s portfolio and strengthen market adoption in key geographies.

Elanco Tech Stack

Elanco uses 8 technology products and services including TOGAF, Veeva Vault, IBM Maximo, and more. Explore Elanco's tech stack below.

  • TOGAF
    Business Process Management
  • Veeva Vault
    Enterprise Content Management
  • IBM Maximo
    Facilities Management
  • Azure AI Services
    Intelligence And Analytics
  • Cisco SD-WAN
    Network Management
  • Visual Basic .NET
    Programming
  • PowerShell
    Security
  • Tableau Prep
    Visualisation Software

Media & News

Elanco's Email Address Formats

Elanco uses at least 2 format(s):
Elanco Email FormatsExamplePercentage
First.Last@elanco.comJohn.Doe@elanco.com
55%
Last_First@elanco.comDoe_John@elanco.com
32%
FirstLast@elanco.comJohnDoe@elanco.com
8%
FLast@elanco.comJDoe@elanco.com
5%
First.Last@network.elanco.comJohn.Doe@network.elanco.com
59%
Last_First@network.elanco.comDoe_John@network.elanco.com
20%
LastFir@network.elanco.comDoeJoh@network.elanco.com
13%
LFirst@network.elanco.comDJohn@network.elanco.com
8%

Frequently Asked Questions

What is Elanco's phone number?

Minus sign iconPlus sign icon
You can contact Elanco's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Elanco's stock symbol?

Minus sign iconPlus sign icon
Elanco is a publicly traded company; the company's stock symbol is ELAT.

What is Elanco's official website and social media links?

Minus sign iconPlus sign icon
Elanco's official website is elanco.com and has social profiles on LinkedInCrunchbase.

What is Elanco's NAICS code?

Minus sign iconPlus sign icon
Elanco's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Elanco have currently?

Minus sign iconPlus sign icon
As of July 2026, Elanco has approximately 9.2K employees across 6 continents, including North AmericaEuropeAsia. Key team members include Cfo Casa - Central & South America (ex. Brazil): D. A.Cfo Mexico: M. P.Cfo - Asean, India & Bangladesh: H. Y. L.. Explore Elanco's employee directory with LeadIQ.

What industry does Elanco belong to?

Minus sign iconPlus sign icon
Elanco operates in the Pharmaceutical Manufacturing industry.

What technology does Elanco use?

Minus sign iconPlus sign icon
Elanco's tech stack includes TOGAFVeeva VaultIBM MaximoAzure AI ServicesCisco SD-WANVisual Basic .NETPowerShellTableau Prep.

What is Elanco's email format?

Minus sign iconPlus sign icon
Elanco's email format typically follows the pattern of First.Last@elanco.com. Find more Elanco email formats with LeadIQ.

How much funding has Elanco raised to date?

Minus sign iconPlus sign icon
As of July 2026, Elanco has raised $253M in funding. The last funding round occurred on Dec 30, 2023 for $250M.
Elanco logo

Elanco

Pharmaceutical ManufacturingIndiana, United States5001-10000 Employees

Elanco operates in the pharmaceutical manufacturing sector with a focus on animal health. Headquartered in Indianapolis, Indiana, it maintains a broad portfolio of brands and an active development pipeline aimed at improving outcomes for animals and the people who care for them.

Its customers include veterinarians, pet owners, and farming communities involved in animal care. The company has pursued initiatives such as developing treatments for serious canine diseases, reducing the need for injections in diabetes care, and pursuing sustainable market opportunities for farmers.

Section iconCompany Overview

Phone number
Website
elanco.com
Stock Symbol
ELAT
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
5001-10000

Section iconMedia & News

Section iconFunding & Financials

  • $253M

    Elanco has raised a total of $253M of funding over 2 rounds. Their latest funding round was raised on Dec 30, 2023 in the amount of $250Mas a post_ipo_equity.

  • $1B$10B

    Elanco's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $253M

    Elanco has raised a total of $253M of funding over 2 rounds. Their latest funding round was raised on Dec 30, 2023 in the amount of $250Mas a post_ipo_equity.

  • $1B$10B

    Elanco's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.